Opening book details…
About this nonfiction
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia by Siskind, Dan (author);Baker, Andrea (author);Arnautovska, Urska (author);Warren, Nicola (author);Russell, Anthony (author);DeMonte, Veronica (author);Halstead, Sean (author);Iyer, Ravi (author);Korman, Nicole (author);McKeon, Gemma (author);Medland, Sarah (author);Parker, Stephen (author);Stedman, Terry (author);Trott, Mike (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- Siskind, Dan (author);Baker, Andrea (author);Arnautovska, Urska (author);Warren, Nicola (author);Russell, Anthony (author);DeMonte, Veronica (author);Halstead, Sean (author);Iyer, Ravi (author);Korman, Nicole (author);McKeon, Gemma (author);Medland, Sarah (author);Parker, Stephen (author);Stedman, Terry (author);Trott, Mike (author)
- Publisher
- Elsevier BV
- Published
- 2025
- Language
- EN
- Category
- nonfiction
More by Siskind, Dan (author);Baker, Andrea (author);Arnautovska, Urska (author);Warren, Nicola (author);Russell, Anthony (author);DeMonte, Veronica (author);Halstead, Sean (author);Iyer, Ravi (author);Korman, Nicole (author);McKeon, Gemma (author);Medland, Sarah (author);Parker, Stephen (author);Stedman, Terry (author);Trott, Mike (author)
Similar books
- Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial — McGowan, Barbara M; Bruun, Jens M; Capehorn, Matt; Pedersen, Sue D; Pietiläinen, Kirsi H; Muniraju, Hanna Angelene Kudiyanur; Quiroga, Maria; Varbo, Anette; Lau, David C W (2024)
- Naltrexone 6 Mg Once Daily Versus Placebo in Women with Fibromyalgia: a Randomised, Double-blind, Placebo-controlled Trial — Due Bruun, Karin; Christensen, Robin; Amris, Kirstine; Vaegter, Henrik Bjarke; Blichfeldt-Eckhardt, Morten Rune; Bye-Møller, Lars; Holsgaard-Larsen, Anders; Toft, Palle (2023)
- Efficacy and Safety of Brexpiprazole in Adolescents with Schizophrenia: a Multicountry, Randomised, Double-blind, Placebo-controlled, Phase 3 Trial with an Active Reference — Ward, Caroline; Pejović Milovančević, Milica; Kohegyi, Eva; Hefting, Nanco; Aurang, Catherine; Chen, Dalei; Larsen, Klaus Groes; Hobart, Mary; Correll, Christoph U (2025)
- Oral Semaglutide 50 Mg Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1): a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial — Knop, Filip K; Aroda, Vanita R; do Vale, Ruben D; Holst-Hansen, Thomas; Laursen, Peter N; Rosenstock, Julio; Rubino, Domenica M; Garvey, W Timothy (2023)
- Semaglutide and Walking Capacity in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes (STRIDE): a Phase 3b, Double-blind, Randomised, Placebo-controlled Trial — Marc P Bonaca MD & Andrei-Mircea Catarig MD & Prof Kim Houlind MD & Prof Bernhard Ludvik MD & Prof Joakim Nordanstig MD PhD & Chethana Kalmady Ramesh MSc & Prof Neda Rasouli MD & Prof Harald Sourij MD MBA & Alex Videmark MD & Prof Subodh Verma MD PhD &... (2025)
- Atosiban Versus Placebo for Threatened Preterm Birth (APOSTEL 8): a Multicentre, Randomised Controlled Trial — van der Windt, Larissa I; Klumper, Job; Duijnhoven, Ruben G; Kok, Marjolein; Ris-Stalpers, Carrie; de Boer, Marjon A; van Kaam, Anton H; Pajkrt, Eva; Mol, Ben W; Walker, Kate F; McAuliffe, Fionnuala M; van der Post, Joris A; Roos, Carolien; Oudijk, Martijn A; Schaaf, Jelle M; van Eyck, Jim; Knol, H Marieke; Sueters, Marieke; Scheepers, Liesbeth H C J; van der Ham, David P; van Laar, Judith O E H; van den Akker, Eline S A; Scholten, Ralph R; van Gemund, Nicolette; Vollebregt, Karlijn C; Visser, Harrie; Gordijn, Sanne J; Bekker, Mireille N; Langenveld, Josje (2025)